Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Central nervous system involvement in chronic lymphocytic leukemia: a real-world analysis.
Journal: Leukemia & lymphoma
Published: November 18, 2025
5-5-5 ABRT (Dose of 5 Gy per Fraction for up to 5 Fractions Over 5 Weeks Adaptive Bridging Radiation Therapy)-Artificial Intelligence Enters the CAR (-T) (Chimeric Antigen Receptor-T) in Relapsed/Refractory Large B Cell Lymphoma.
Journal: International journal of radiation oncology, biology, physics
Published: November 04, 2024
Longitudinal Patient-Reported Outcomes in Older Adults With Aggressive Lymphomas Receiving Chemoimmunotherapy.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 19, 2024
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL.
Journal: Blood advances
Published: September 01, 2023
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.
Journal: Neuro-oncology
Published: July 04, 2023
Metabolic parameters predict survival and toxicity in chimeric antigen receptor T-cell therapy-treated relapsed/refractory large B-cell lymphoma.
Journal: Hematological oncology
Published: June 05, 2023
Venetoclax activity in a patient with central nervous system involvement by chronic lymphocytic leukaemia.
Journal: The Lancet. Haematology
Published: December 04, 2021
Last Updated: 09/26/2026